Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,517 | 249 | 86.7% |
| Travel and Lodging | $762.93 | 2 | 12.0% |
| Education | $84.99 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,720 | 98 | $0 (2024) |
| Genentech USA, Inc. | $1,314 | 4 | $0 (2024) |
| Gilead Sciences, Inc. | $834.64 | 67 | $0 (2024) |
| Medtronic, Inc. | $322.38 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $268.70 | 6 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $245.73 | 8 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $186.99 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $181.54 | 9 | $0 (2024) |
| Madrigal Pharmaceuticals | $177.94 | 4 | $0 (2024) |
| Novo Nordisk Inc | $172.45 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,011 | 122 | Genentech USA, Inc. ($1,314) |
| 2023 | $1,216 | 77 | ABBVIE INC. ($456.50) |
| 2022 | $820.98 | 40 | ABBVIE INC. ($341.46) |
| 2021 | $316.07 | 13 | AbbVie Inc. ($145.81) |
All Payment Transactions
252 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.39 | General |
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/27/2024 | Medtronic, Inc. | ENDOFLIP (Device) | Food and Beverage | In-kind items and services | $99.58 | General |
| Category: Motility Testing | ||||||
| 11/25/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: LIVER DISEASE | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $10.00 | General |
| 11/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/14/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug), STELARA, REMICADE | Food and Beverage | In-kind items and services | $84.73 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.06 | General |
| 11/12/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $32.45 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: LIVER DISEASE | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $119.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: VIROLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.24 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $32.03 | General |
| Category: LIVER DISEASE | ||||||
| 10/23/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Immunology | ||||||
| 10/18/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $289.40 | General |
| 10/17/2024 | Genentech USA, Inc. | — | Travel and Lodging | Cash or cash equivalent | $386.25 | General |
| 10/17/2024 | Genentech USA, Inc. | — | Travel and Lodging | Cash or cash equivalent | $376.68 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 309 | 442 | $98,700 | $23,876 |
| 2022 | 4 | 239 | 308 | $70,790 | $17,039 |
| 2021 | 2 | 190 | 264 | $57,262 | $14,502 |
| 2020 | 3 | 198 | 276 | $56,143 | $11,761 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 140 | 252 | $57,960 | $14,824 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 100 | 121 | $18,150 | $4,697 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 45 | 45 | $17,190 | $3,597 | 20.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 24 | 24 | $5,400 | $757.80 | 14.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 103 | 163 | $37,744 | $9,307 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 75 | 84 | $12,600 | $3,401 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 42 | 42 | $16,171 | $3,358 | 20.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 19 | 19 | $4,275 | $972.75 | 22.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 119 | 185 | $44,662 | $11,237 | 25.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 71 | 79 | $12,600 | $3,265 | 25.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 123 | 188 | $43,544 | $8,958 | 20.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 53 | 63 | $9,456 | $1,951 | 20.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 22 | 25 | $3,143 | $853.22 | 27.1% |
About Kelli Martin, FNP-C
Kelli Martin, FNP-C is a Nurse Practitioner healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2018. The National Provider Identifier (NPI) number assigned to this provider is 1942787528.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kelli Martin, FNP-C has received a total of $6,364 in payments from pharmaceutical and medical device companies, with $4,011 received in 2024. These payments were reported across 252 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($5,517).
As a Medicare-enrolled provider, Martin has provided services to 936 Medicare beneficiaries, totaling 1,290 services with total Medicare billing of $67,179. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Tyler, TX
- Active Since 07/25/2018
- Last Updated 08/11/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1942787528
Products in Payments
- RINVOQ (Biological) $589.72
- MAVYRET (Drug) $340.43
- STELARA (Biological) $254.09
- SKYRIZI (Biological) $250.31
- CREON (Drug) $246.27
- REBYOTA (Biological) $222.64
- TREMFYA (Drug) $201.60
- Epclusa (Drug) $157.51
- MANOSCAN (Device) $156.86
- OCALIVA (Drug) $155.49
- HUMIRA (Biological) $153.44
- XIFAXAN (Drug) $148.19
- OMVOH (Drug) $138.48
- Wegovy (Drug) $133.50
- REZDIFFRA (Drug) $110.88
- ENDOFLIP (Device) $99.58
- ENTYVIO (Biological) $87.22
- DUPIXENT (Biological) $85.78
- RESMETIROM (Drug) $67.06
- VIBERZI (Drug) $66.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Tyler
Roger Chapman, Fnp-C, FNP-C
Nurse Practitioner — Payments: $164,372
David Mccaskill, Fnp-C, Acnp, FNP-C, ACNP
Nurse Practitioner — Payments: $13,081
John Campbell, Fnp, FNP
Nurse Practitioner — Payments: $7,974
Mr. Francisco Rivera, Fnp,Acnp, FNP,ACNP
Nurse Practitioner — Payments: $7,776
Mrs. Constance Bentley, Aprn, APRN
Nurse Practitioner — Payments: $7,756
Kimberly Brown, Fnp, FNP
Nurse Practitioner — Payments: $7,552